ALGORITHM FOR DIAGNOSING WILLEBRAND'S DISEASE
Main Article Content
Abstract
Willebrand's disease is the most common hereditary coagulopathy caused by a decrease in the amount or impaired function of Willebrand factor (vWF). It occurs in 0.5-1 % of the population, the prevalence of clinically significant forms is 1-2 per 10000 people. Depending on the nature of Willebrand factor disorders, there are three main types of Willebrand's disease. Each of these categories corresponds to certain pathophysiological mechanisms, which largely correlate with clinical features and therapeutic requirements. Cooperation of the Kuzbass Clinical Hospital and ROSMED online platforms.INFO in 2021 allowed the second stage of diagnosis to be carried out by laboratory testing of specific coagulological tests for the diagnosis of the type of Willebrand's disease. The study made it possible to verify the diagnosis of Willerbrand's disease depending on the type and to make a correction in therapy.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Dupervil B, Abe K, O'Brien SH, Oakley M, Kulkarni R, Thornburg CD, et al. Characteristics, complications, and sites of bleeding among infants and toddlers less than 2 years of age with VWD. Blood Adv. 2021; 5(8): 2079-2086. doi: 10.1182/bloodadvances.2020004141
Soucie JM, Miller CH, Byams VR, Payne AB, Abe K, Sidonio RF, Kouides PA. Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States. Haemophilia. 2021; 27(3): 445-453. doi: 10.1111/hae.14263
Abe K, Dupervil B, O'Brien SH, Oakley M, Kulkarni R, Gill JC, Byams V, Soucie MJ. Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease. Am J Hematol. 2020; 95(1): 10-17. doi: 10.1002/ajh.25656
Srivaths LV, Zhang QC, Byams VR, Dietrich JE, James AH, Kouides PA, Kulkarni R. Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding. Haemophilia. 2018; 24(1): 63-69. doi: 10.1111/hae.13330
Boylan B, Rice AS, De Staercke C, Eyster ME, Yaish HM, Knoll CM, et al. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations. J Thromb. Haemost. 2015; 13(6): 1036-1042. doi: 10.1111/jth.12902
Sood SL, Cuker A, Wang C, Metjian AD, Chiang EY, Soucie JM, Konkle BA. Similarity in joint function limitation in Type 3 von Willebrand's disease and moderate haemophilia A. Haemophilia. 2013; 19(4): 595-601. doi: 10.1111/hae.12119
Byams VR, Kouides PA, Kulkarni R, Baker JR, Brown DL, Gill JC, et al. Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres. Haemophilia. 2011; 17, Suppl. 1(01): 6-13. doi: 10.1111/j.1365-2516.2011.02558.x
Castaman G, Linari S. Diagnosis and treatment of von Willebrand disease and rare bleeding disorders. J. Clin. Med. 2017; 6(4): 45. doi: 10.3390/jcm6040045
Nikolaeva LB, Ushakova GA, Elgina SI. The forecast of reproduction of the population and reproductive health of girls of Kuzbass. Mother and Baby in Kuzbass. 2010; (1): 19-27. Russian (Николаева Л.Б., Ушакова Г.А., Елгина С.И. Прогноз воспроизводства населения и репродуктивное здоровье девочек Кузбасса //Мать и Дитя в Кузбассе. 2010. № 1. С. 19-27)
Fundamentals of Clinical Hemostasiology and Hemorheology /eds. Davydkina IL, Momota AP, Zozuly NI, Roitman EV. Samara: LLC IPK «Samara Province», 2017. 484 p. Russian (Основы клинической гемостазиологии и гемореологии /под ред. И.Л. Давыдкина, А.П. Момота, Н.И. Зозули, Е.В. Ройтмана. Самара: ООО ИПК «Самарская Губерния», 2017. 484 с.)
Laffan MA, Lester W, O'Donnell JS, Will A, Tait RC, Goodeve A, et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br. J. Haematol. 2014; 167(4): 453-465. doi: 10.1111/bjh.13064
Favaloro EJ, Bonar RA, Meiring M, Duncan E, Mohammed S, Sioufi J, Marsden K. Evaluating errors in the laboratory identification of von Willebrand disease in the real world. Thromb. Res. 2014; 134(2): 393-403. doi: 10.1016/j.thromres.2014.05.020
National Hematological Society. Clinical guidelines for the diagnosis and treatment of von Willebrand disease. 2018. 30 p. Russian (Национальное гематологическое общество. Клинические рекомендации по диагностике и лечению болезни Виллебранда. 2018. 30 с.)